ClinConnect ClinConnect Logo
Search / Trial NCT06293586

Comparison Between Peribulbar And Sub-tenon Blocks on Oculocardiac Reflex (OCR) During Pediatric Strabismus Surgery

Launched by CAIRO UNIVERSITY · Feb 27, 2024

Trial Information

Current as of July 21, 2025

Recruiting

Keywords

Paracetamol Peribulbar Block Sub Tenon Block Pediatric Strabismus Surgery Oculocardiac Reflex

ClinConnect Summary

This clinical trial is looking at two different ways to give anesthesia to children undergoing eye surgery for strabismus, a condition where the eyes do not properly align. The study aims to compare the effectiveness of two local anesthesia techniques—peribulbar block and subtenon block—alongside general anesthesia. Researchers want to see how these methods affect the oculocardiac reflex, which is a response that can happen during eye surgery, as well as how well pain is managed after the surgery and the occurrence of vomiting afterward.

The trial is open to children aged 6 to 13 years who are generally healthy and scheduled for this type of surgery. However, children with specific eye problems, certain health conditions, or allergies to anesthesia medications cannot participate. If enrolled, participants can expect to receive one of the anesthesia techniques during their surgery and will be monitored closely for any side effects. This study will help doctors understand the best ways to manage anesthesia for kids undergoing eye surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants were children (6-13 years), ASA I-II patients, scheduled to undergo strabismus surgery.
  • Exclusion Criteria:
  • Children with tumors or infections of the orbit, raised intraocular pressure more than 20 mm Hg, axial length more than 28 mm, eye injury, airway abnormalities or who were blind in the eye other than that which was to be operated on were excluded. Other exclusion criteria included patients undergoing revision surgery, known allergy to local anesthetics or non-steroidal antiinflammatory drugs (NSAIDs), steroid therapy, parental refusal to participate and patients with INR more than 1.5 or with platelets less than 100.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported